Letvimo Capsules 80mg

Letvimo Capsules 80mg, from Eli Lilly Japan, contains Selpercatinib (YJ code: 4291075M2023, standard: 80mg 1 capsule). This medication is a selective RET kinase inhibitor, targeting RET gene fusions and mutations that are implicated in various cancers. Its mechanism of action involves inhibiting the RET receptor kinase to block growth signals and prevent tumor cell proliferation.